brivudina aristo 125 mg comprimidos efg
aristo pharma gmbh - brivudina - comprimido - 125 mg - brivudina 125 mg - brivudina
clindamicina aristo 100 mg ovulos
aristo pharma gmbh - clindamicina fosfato - Óvulo - 100 mg - clindamicina fosfato 100 mg - clindamicina
ziprasidona pharmacia 20 mg capsulas duras efg
pharmacia nostrum, s.a. - ziprasidona hidrocloruro - excipientes: lactosa monohidrato,almidon de maiz pregelatinizado,capsulas de gelatina dura - antipsicÓticos - derivados del indol - ziprasidona
ziprasidona pharmacia 40 mg capsulas duras efg
pharmacia nostrum, s.a. - ziprasidona hidrocloruro - excipientes: lactosa monohidrato,almidon de maiz pregelatinizado,capsulas de gelatina dura - antipsicÓticos - derivados del indol - ziprasidona
ziprasidona pharmacia 60 mg capsulas duras efg
pharmacia nostrum, s.a. - ziprasidona hidrocloruro - excipientes: lactosa monohidrato,almidon de maiz pregelatinizado,capsulas de gelatina dura - antipsicÓticos - derivados del indol - ziprasidona
ziprasidona pharmacia 80 mg capsulas duras efg
pharmacia nostrum, s.a. - ziprasidona hidrocloruro - excipientes: lactosa monohidrato,almidon de maiz pregelatinizado,capsulas de gelatina dura - antipsicÓticos - derivados del indol - ziprasidona
azitromicina mylan pharmaceuticals 250 mg comprimidos recubiertos con pelicula efg
mylan pharmaceuticals, s.l. - azitromicina monohidrato - excipientes: almidon pregelatinizado,carboximetilalmidon sodico,laurilsulfato de sodio - macrÓlidos, lincosamidas y estreptograminas - macrólidos - azitromicina
tetmodis 25 mg comprimidos efg
aop orphan pharmaceuticals gmbh - tetrabenazina - comprimido - 25 mg - tetrabenazina 25 mg - tetrabenazina
bicarbonato de sosa torres muñoz polvo para solucion oral
haleon spain s.a. - sodio bicarbonato - polvo oral - 1.000 mg/g - sodio bicarbonato 1000 mg - antiácidos con bicarbonato de sodio
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - agentes antineoplásicos - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.